Ghizlane Lyamani, Imane Rahmou
Abstract
Multiple sclerosis is an auto immune demyelinating and debilitating disease. It affects many people in the world and is the main cause of chronic neurological handicap in young adults. The first treatments were based on the immunossupressives which have been replaced during the last years by biotherapies injectables initially and recently oral forms emerged providing prescribers and patients multiple choices according to the cases.